referral-south-africa — open questions

• Has SAHPRA extended dupilumab’s atopic dermatitis registration below 6 years since the May 2024 PIL, and is it funded by any SA medical scheme for toddlers?
• Has the 2014/15 SA atopic dermatitis guideline (Sinclair, Aboobaker, Green et al.) been formally revised since the 2020 Kannenberg algorithm, and what was ALLSA’s formal role?
• Which specific traditional/herbal preparations are used on toddler eczema in South Africa, and have any been tested for undeclared corticosteroids?
• Does a written eczema action plan alone (without a full education programme) improve outcomes in toddlers?